OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

2.33
Delayed Data
As of 12:30pm ET
 +0.01 / +0.43%
Today’s Change
1.74
Today|||52-Week Range
3.73
+1.75%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues5.5M20.1M29.9M27.1M
 
 
 
 
 
Depreciation And Amortization75.0K100.0K227.0K223.0K
 
 
 
 
 
 
Operating ExpensesGross Income5.4M------
 
 
General Expenses27.7M47.6M65.0M56.6M
 
 
 
 
 
Research And Development21.6M39.9M55.3M46.2M
 
 
 
 
 
Total Operating Expenses27.8M47.7M65.2M56.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-22.3M-27.6M-35.3M-29.7M
 
 
 
 
 
Extraordinary Credit7.4M6.3M3.2M4.0M
 
 
 
 
 
Extraordinary Charge0.000.000.00-531.0K
 
 
Other Expenses6.0K-62.0K120.0K-19.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.7M-21.1M-31.8M-26.2M
 
 
 
 
 
Net Income-14.7M-21.1M-31.8M-26.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.7M13.5M14.7M18.1M
 
 
 
 
 
Shares To Calculate EPS Diluted9.7M13.5M14.7M18.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.51-$1.56-$2.17-$1.45
 
 
 
 
 
EPS Diluted-$1.51-$1.56-$2.17-$1.45
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account